Is it Possible to Treat Osteosarcoma Using Oligonucleotides Confined into Controlled Release Drug Delivery Systems?


Topuk S., Akyuva Y., Karaaslan N., Mutlu C. A. , Yilmaz I., Isyar M., ...More

CURRENT PHARMACEUTICAL BIOTECHNOLOGY, vol.18, no.6, pp.516-522, 2017 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 18 Issue: 6
  • Publication Date: 2017
  • Doi Number: 10.2174/1389201018666170615083455
  • Title of Journal : CURRENT PHARMACEUTICAL BIOTECHNOLOGY
  • Page Numbers: pp.516-522

Abstract

Purpose: The present study aimed to analyze the researches that are at the experimental phase concerning osteosarcoma treatment. The researches included drug delivery systems which allow controlled release and imbue small interfering-/micro-ribonucleic acid.